Back to today’s briefing

Story perspectives

FDA-Approved Drugs Offer Hope for Autism, OCD Treatments

5/20/2025

50 10

Summary

Story summary

Chronic brain inflammation caused by a mutated NLRP3 gene has been linked to repetitive behaviors associated with autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD). In mice, this inflammation triggered anxiety and compulsive actions. However, FDA-approved drugs memantine and interleukin-1RA successfully restored normal brain function, opening doors for innovative treatments for those affected by ASD and OCD.

1 of 1

Story summary

Chronic brain inflammation caused by a mutated NLRP3 gene has been linked to repetitive behaviors associated with autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD). In mice, this inflammation triggered anxiety and compulsive actions. However, FDA-approved drugs memantine and interleukin-1RA successfully restored normal brain function, opening doors for innovative treatments for those affected by ASD and OCD.